Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
657
Sort by:
Molecular Diagnostics Market Report: 2011 Edition
US$ 800.00
... , QIAGEN, Bayer, Abbott, and Becton Dickinson. The current report analyzes the molecular diagnostic market on the global basis. It also presents a view of the various ...
June 2011
43 pages
Infectious Disease Molecular Diagnostic Testing
US$ 2,000.00
Global PDF: US$ 5,500.00 The report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. Contains 360 pages and 20 tables
February 2010
360 pages
The World Market for Molecular Diagnostics
US$ 3,995.00
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platf...
January 2009
450 pages
